Titus Regional Medical Center’s award winning and innovative Stroke Program is led by quadruple board certified Dr. Saud Khan. The highly skilled interdisciplinary team is trained in evidenced based stroke care. Certified and designated by both the Joint Commission of Healthcare and the State of Texas as Primary Stroke Center, we strictly follow evidence from Clinical Practice Guidelines developed by the American Heart/Stroke Association. At Titus Regional Medical Center, we’re committed to providing stroke care that aligns with the latest research-based treatment guidelines. Studies show patients can recover better when these guidelines are consistently followed. We’re proud to be recognized by the American Heart/Stroke Association for our achievement in the Get With The Guidelines® Registry as a Stroke Gold Plus Quality award winning hospital. In addition, TRMC is on the Stroke Honor Roll for 2018, achieving the highest designation of Target Stroke Honor Roll Elite Plus. Continuity of care is very important for a stroke patients, we have developed a pathway for our patients for rapid follow up after hospital discharge at Neurology Center at Titus. This allows for rapid identification and possible interventions that optimize the health of stroke victims in our community. This is just another way Titus Regional Medical Center is working to improve healthcare for you and your family.
This is what the American Heart/Stroke Association has to say about our coveted awards:
Gold Plus Recognition
“Hospitals receiving Get With The Guidelines® Gold Plus Achievement Award have reached an aggressive goal of treating patients with 85 percent or higher compliance to core standard levels of care as outlined by the American Heart Association/American Stroke Association® for 2 consecutive calendar years. In addition, those hospitals have demonstrated 75 percent compliance to (four out of ten heart failure quality measures or seven out of ten stroke quality measures) during the 12-month period.”
Target: Stroke Honor Roll Elite Plus
“Hospitals achieving Time to Intravenous Thrombolytic Therapy within ≤ 45 minutes in 75 percent or more of applicable acute ischemic stroke patients treated with IV Thrombolytic AND door-to-needle time to Intravenous Thrombolytic Therapy within ≤ 30 minutes in 50 percent of applicable acute ischemic stroke patients treated with IV Thrombolytic to improve quality of patient care and outcomes.”